Subscribe

Olga Uspenskaya, MD, PhD

Articles by Olga Uspenskaya, MD, PhD

Olga Uspenskaya, MD, PhD

Working Toward a Single Dose Gene Therapy for Type 1 Gaucher Disease

ByOlga Uspenskaya, MD, PhD

January 31st 2023

Olga Uspenskaya, MD, PhD, vice president, clinical development, Prevail Therapeutics, discussed the PROCEED trial of PR001.

Latest Updated Articles

Working Toward a Single Dose Gene Therapy for Type 1 Gaucher Disease
Published: January 31st 2023 | Updated:

Trending on CGTlive®

CGTLive®’s Weekly Rewind – October 31, 2025

Quarter Century Update: Thoughts on Reducing Costs of Goods

© 2025 MJH Life Sciences^®

All rights reserved.